Skip to content

Impact of methylprednisolone on postoperative rehabilitation of patients undergoing fast track thoracoscopic pneumonectomy surgery: a randomized controlled trial

Impact of methylprednisolone on postoperative rehabilitation of patients undergoing fast track thoracoscopic pneumonectomy surgery: : a randomized controlled trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900021020
Enrollment
Unknown
Registered
2019-01-25
Start date
2019-01-28
Completion date
Unknown
Last updated
2021-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung tumor

Interventions

low dose methylprednisolone:injevt 40mg methylprednisolone introvenous
high dose methylprednisolone:injevt 120mg methylprednisolone introvenous
control group :injevt normal saline introvenous

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged at least 18 years; 2. ASA I ~ III; 3. Selective thoracoscopic pneumonectomy; 4. Signing informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with gastrointestinal ulcer or allergic reaction; 2. Diabetic patients; 3. Long-term use of glucocorticoids before operation; 4. Chronic pain existed before operation. 5. Re-operation or conversion to thoracotomy is needed; 6. Postoperative admission to ICU.

Design outcomes

Primary

MeasureTime frame
the proportion of moderate-to-severe pain on the first day postoperatively;

Secondary

MeasureTime frame
pain scores within 3 days after surgery;the rate of post-operative nausea and vomitting;postoperative quality of recovery scores;IL-6, CRP, and fasting blood sugar;Length of hospital stay;the rate of rescue analgesia;

Countries

China

Contacts

Public ContactHai Yu

37 Guoxue Lane, Wuhou District, Chengdu, Sichuan, China

yuhaishan117@yahoo.com+86 18980601548

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 21, 2026